Zenas BioPharma, Bicara Therapeutics Sets IPO Price Ranges as Summer Lull Ends
Zenas BioPharma, Bicara Therapeutics Sets IPO Price Ranges as Summer Lull Ends
Zenas BioPharma和Bicara Therapeutics設定了首次公開發行價格範圍,夏季低迷接近尾聲。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊